Figure 4
From: Oncogenic role and potential regulatory mechanism of topoisomerase IIα in a pan-cancer analysis
Genetic alteration analysis of TOP2A. (A,B) The alteration frequency with mutation type (A) and mutation site (B) in a pan-cancer analysis. (C) The correlation between TOP2A mutation status and overall, disease-specific, disease-free and progression-free survival in UCEC. (D) The correlation between TOP2A mutation status and overall, disease-specific, and progression-free survival in ACC. (E) The correlation between TOP2A mutation status and overall, disease-specific, and progression-free survival in OV.
